World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
180
Citations
138502
World Ranking
613
National Ranking
385

Medicine

D-Index
181
Citations
146118
World Ranking
353
National Ranking
221

Robert J. Glynn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert J. Glynn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 897 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert J. Glynn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert J. Glynn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 181 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Robert J. Glynn is affiliated with Harvard Medical School in the United States, contributing extensively to the field of Medicine, with a particular focus on subfields such as Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Statistics and Probability, Economics and Econometrics, and Surgery.

Their research covers a range of topics including Health Systems, Economic Evaluations, Quality of Life, Diabetes Treatment and Management, Advanced Causal Inference Techniques, Lipoproteins and Cardiovascular Health, Statistical Methods in Clinical Trials, Diabetes Management and Research, as well as Metabolism, Diabetes, and Cancer.

Notable recent publications include:

  • Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials, 2023, The Lancet
  • The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials, 2020, European Heart Journal
  • Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, 2023, JAMA
  • Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies, 2020, Circulation
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet

Frequent co-authors in their publications include Sebastian Schneeweiß, Paul M. Ridker, Elisabetta Patorno, Deborah J. Wexler, and Brendan M. Everett.

Their work has been published across various venues, with multiple contributions to UNC Libraries, Circulation, Journal of the American College of Cardiology, Annals of Internal Medicine, and Clinical Pharmacology & Therapeutics.

Best Publications

  • A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.

    Jack M. Guralnik;Eleanor M. Simonsick;Luigi Ferrucci;Robert J. Glynn

  • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

    Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest

  • Variable Selection for Propensity Score Models

    M. Alan Brookhart;Sebastian Schneeweiss;Kenneth J. Rothman;Kenneth J. Rothman;Robert J. Glynn

  • Long-term persistence in use of statin therapy in elderly patients☆

    J.S. Benner;R.J. Glynn;H. Mogun;P.J. Neumann

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

    Paul M. Ridker;Robert J. Glynn;Charles H. Hennekens

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

    Paul M Ridker;Eleanor Danielson;Francisco Ah Fonseca;Jacques Genest

  • Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

    Paul M Ridker;Samuel Z. Goldhaber;Ellie Danielson;Yves Rosenberg

  • Vitamins E and C in the Prevention of Cardiovascular Disease in Men : The Physicians' Health Study II Randomized Controlled Trial

    Howard D. Sesso;Julie E. Buring;William G. Christen;Tobias Kurth

  • High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

    Sebastian Schneeweiss;Jeremy A. Rassen;Robert J. Glynn;Jerry Avorn

  • Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

    Paul M Ridker;Brendan M Everett;Aruna Pradhan;Jean G MacFadyen

  • Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

    Edward W. Campion;Robert J. Glynn;Lorraine O. Delabry

  • Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

    Paul M Ridker;Aruna Pradhan;Jean G MacFadyen;Peter Libby

  • Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

    BF Gage;C Eby;JA Johnson;E Deych

  • A combined comorbidity score predicted mortality in elderly patients better than existing scores

    Joshua J. Gagne;Robert J. Glynn;Jerry Avorn;Raisa Levin

  • A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

    Robert J. Glynn;Eleanor Danielson;Francisco A.H. Fonseca;Jacques Genest

  • Reduction of bacteriuria and pyuria after ingestion of cranberry juice.

    Jerry Avorn;Mark Monane;Jerry H. Gurwitz;Robert J. Glynn

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

Frequent Co-Authors

Paul M. Ridker
Paul M. Ridker Brigham and Women's Hospital
Sebastian Schneeweiss
Sebastian Schneeweiss Brigham and Women's Hospital
Julie E. Buring
Julie E. Buring Brigham and Women's Hospital
Jerry Avorn
Jerry Avorn Brigham and Women's Hospital
JoAnn E. Manson
JoAnn E. Manson Harvard Medical School
J. Michael Gaziano
J. Michael Gaziano Brigham and Women's Hospital
Til Stürmer
Til Stürmer University of North Carolina at Chapel Hill
Bernard Rosner
Bernard Rosner Harvard University
Daniel H. Solomon
Daniel H. Solomon Brigham and Women's Hospital
Howard D. Sesso
Howard D. Sesso Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare but seeking flexible study options, there are several online degree pathways to consider. Many registered nurses look for affordable ways to advance their education, making it important to compare rn to bsn online cost before enrolling.

If you do not yet have a nursing background, some universities offer direct entry msn programs specifically designed for non-nurses. These can fast-track your transition into advanced nursing roles in less time.

Those looking for a quicker start in nursing can explore adn programs, which provide an Associate Degree in Nursing and a pathway to becoming a registered nurse.

Alternatively, supporting healthcare through administration is highly accessible online. Consider enrolling in one of the top medical billing and coding schools online with financial aid to enter the healthcare administrative field from home.

Exploring these online degrees offers flexibility, affordability, and new career opportunities within medicine and healthcare.

Best Scientists Citing Robert J. Glynn

Trending Scientists

Recently Published Articles